The estimated Net Worth of Ourania Tatsis is at least $32.4 Million dollars as of 3 June 2024. Ourania Tatsis owns over 2,175 units of Vertex Pharmaceuticals stock worth over $23,308,785 and over the last 5 years Ourania sold VRTX stock worth over $9,111,810.
Ourania has made over 26 trades of the Vertex Pharmaceuticals stock since 2019, according to the Form 4 filled with the SEC. Most recently Ourania sold 2,175 units of VRTX stock worth $1,000,500 on 3 June 2024.
The largest trade Ourania's ever made was selling 5,750 units of Vertex Pharmaceuticals stock on 10 August 2023 worth over $1,988,293. On average, Ourania trades about 1,004 units every 52 days since 2019. As of 3 June 2024 Ourania still owns at least 49,098 units of Vertex Pharmaceuticals stock.
You can see the complete history of Ourania Tatsis stock trades at the bottom of the page.
Ourania's mailing address filed with the SEC is C/O VERTEX PHARMACEUTICALS INCORPORATED, 50 NORTHERN AVENUE, BOSTON, MA, 02210.
Over the last 21 years, insiders at Vertex Pharmaceuticals have traded over $934,925,905 worth of Vertex Pharmaceuticals stock and bought 308,652 units worth $12,298,449 . The most active insiders traders include Lloyd Carney, Jeffrey M Leiden, and Joshua S Boger. On average, Vertex Pharmaceuticals executives and independent directors trade stock every 5 days with the average trade being worth of $4,747,875. The most recent stock trade was executed by Jeffrey M Leiden on 30 August 2024, trading 3,784 units of VRTX stock currently worth $1,888,216.
Vertex Pharmaceuticals is an American biopharmaceutical company based in Boston, Massachusetts. It was one of the first biotech firms to use an explicit strategy of rational drug design rather than combinatorial chemistry.
Vertex Pharmaceuticals executives and other stock owners filed with the SEC include: